TearLab Corporation (TearLab) announced the appointment of Adam Szaronos to the position of Chief Commercial Officer (CCO). Mr. Szaronos brings a wealth of experience gained over the past 15 years and will help guide the evolution of TearLab as it transforms its business model in 2020 and beyond. Mr. Szaronos is joining the TearLab executive team from Alcon, where he was most recently their Head of Dry Eye Devices; responsible for building and leading the company's commercial business unit in the Dry Eye Disease and MGD space. He brings years of comprehensive eye care industry and leadership experience, having led commercial teams and new ventures across Alcon's Surgical and Vision Care organizations. A lifelong learner, he holds an MBA from Massachusetts Institute of Technology'sSloan School of Management, a certificate in Strategic Marketing Management from Harvard Business School, and a Bachelor of Science from Indiana University'sKelley School of Business. Recently, TearLab was acquired by investment firm Accelmed Partners. Following the acquisition, TearLab transitioned from being a publicly traded company to a privately held company and is positioned to pursue further development of its next-generation Discovery™ platform. It is also able to seek out targeted acquisition opportunities supporting a comprehensive portfolio that better addresses dry eye disease market dynamics and patient care needs.